| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/2004 | WO2004064803A1 Topical pharmaceutical and/or cosmetic dispense systems |
| 08/05/2004 | WO2004064798A1 Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
| 08/05/2004 | WO2004064789A2 Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| 08/05/2004 | WO2004064788A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064782A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 08/05/2004 | WO2004064781A2 Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs |
| 08/05/2004 | WO2004064779A2 Use of nitroglycerin to relieve nocturnal muscle cramps |
| 08/05/2004 | WO2004064778A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | WO2004064777A2 Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer |
| 08/05/2004 | WO2004064775A2 Sigma-2 receptor agonists and their use in the treatment of hiv infection |
| 08/05/2004 | WO2004064772A2 Methods and dosage forms with modified viscosity layers |
| 08/05/2004 | WO2004064767A2 Nitric oxide inducing agents |
| 08/05/2004 | WO2004064764A2 Substituted alkyl amido piperidines |
| 08/05/2004 | WO2004064762A2 Novel cocrystallization |
| 08/05/2004 | WO2004064761A2 Therapeutically active compounds |
| 08/05/2004 | WO2004064760A2 Aptamer therapeutics useful in ocular pharmacotherapy |
| 08/05/2004 | WO2004064759A2 Use of tryptanthrin compounds for immune potentiation |
| 08/05/2004 | WO2004064757A2 Absorption enhancing agents |
| 08/05/2004 | WO2004064755A2 Methods for inhibiting proteasome |
| 08/05/2004 | WO2004064753A2 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 08/05/2004 | WO2004064749A2 Compositions for the reduction of hair growth |
| 08/05/2004 | WO2004064748A2 Compositions and methods for treatment of ovarian cancer |
| 08/05/2004 | WO2004064747A2 Treating androgen deficiency in female (adif)-associated conditions with sarms |
| 08/05/2004 | WO2004064743A2 Modified retinoid compounds and their uses |
| 08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 08/05/2004 | WO2004064741A2 Compounds, compositions, and methods |
| 08/05/2004 | WO2004064738A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/05/2004 | WO2004064736A2 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | WO2004064735A2 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | WO2004064734A2 Combination therapies for the treatment of cancer |
| 08/05/2004 | WO2004064733A2 The use of c-raf inhibitors for the treatment of neurodegenerative diseases |
| 08/05/2004 | WO2004064730A2 Compounds, compositions and methods |
| 08/05/2004 | WO2004064728A2 Use of specific tetracycline compounds in therapy |
| 08/05/2004 | WO2004064727A2 Method of cancer treatment using hdac inhibitors |
| 08/05/2004 | WO2004064726A2 Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions |
| 08/05/2004 | WO2004064725A2 Oral compositions and methods for treatment of adverse effects or radiation |
| 08/05/2004 | WO2004064723A2 Inhibitors and methods of use thereof |
| 08/05/2004 | WO2004064721A2 A pyrazolopyrimidine compound and a process for preparing the same |
| 08/05/2004 | WO2004064719A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 08/05/2004 | WO2004064718A2 Irreversible inhibitors of egf receptor tyrosine kinases and uses thereof |
| 08/05/2004 | WO2004064717A2 Cop 1 for treatment of inflammatory bowel diseases |
| 08/05/2004 | WO2004064716A2 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
| 08/05/2004 | WO2004064715A2 Polyhydroxylated pyrrolizidine |
| 08/05/2004 | WO2004064708A2 Solution for nostril wash |
| 08/05/2004 | WO2004064543A1 Compositions containing coenzyme q10 |
| 08/05/2004 | WO2004064542A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | WO2004064539A2 Fat substitutes |
| 08/05/2004 | WO2004056780A3 Tetrahydroquinoline derivatives |
| 08/05/2004 | WO2004056768A3 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| 08/05/2004 | WO2004054557A3 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 08/05/2004 | WO2004050615A3 Method of increasing neutrophil production using 2,3-benzodiazepines |
| 08/05/2004 | WO2004050033A3 Method of treating cancers |
| 08/05/2004 | WO2004050022A3 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | WO2004050015A3 Withania somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof |
| 08/05/2004 | WO2004046104A3 Treatment of lung cells with histone deacetylase inhibitors |
| 08/05/2004 | WO2004045539A9 Anti-microbial agents derived from methionine sulfoximine analogues |
| 08/05/2004 | WO2004045307A3 Dietry supplements and foods product comprising oleylethanolamide |
| 08/05/2004 | WO2004043405A8 Polysaccharide vaccine for staphylococcal infections |
| 08/05/2004 | WO2004043389A3 Methods of treating cancer and related methods |
| 08/05/2004 | WO2004043377A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 08/05/2004 | WO2004041809A3 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands |
| 08/05/2004 | WO2004041257A3 Novel nutraceutical compositions comprising epigallocatechin gallate |
| 08/05/2004 | WO2004039453A3 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof |
| 08/05/2004 | WO2004037234A3 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 08/05/2004 | WO2004037183A3 Phosphodiester inhibitors and nitric oxide modulators for treating peyronie’s disease, arteriosclerosis and other fibrotic diseases |
| 08/05/2004 | WO2004037169A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | WO2004035001A3 Calcium channel agonists for psychotherapeutic use |
| 08/05/2004 | WO2004034962A3 Selective cytokine inhibitory drugs for treating myelodysplastic syndrome |
| 08/05/2004 | WO2004032861A3 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
| 08/05/2004 | WO2004026235A3 Pharmaceutical compositions with improved dissolution |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004021969A3 Non-nucleoside reverse transcriptase inhibitors |
| 08/05/2004 | WO2004014290A3 R-bambuterol, its preparation and therapeutic uses |
| 08/05/2004 | WO2004012746A3 New uses for inhibitors of inosine monophosphate dehydrogenase |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2004010955A3 Cyclooxygenase-2 inhibitors for appetite suppression |
| 08/05/2004 | WO2004002410A3 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors |
| 08/05/2004 | WO2004000226A3 Liposomes containing biologically active compounds |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003077874A3 Substituted tetrahydroisoquinoline compounds, methods of making, and their use |
| 08/05/2004 | WO2003073988A3 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof |
| 08/05/2004 | WO2003070204A3 Lipase inhibiting composition |
| 08/05/2004 | WO2003068144A3 Cytotoxic agents |
| 08/05/2004 | WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 08/05/2004 | WO2003057830A3 Compositions and methods for hydroxylating epothilones |
| 08/05/2004 | WO2003051303A3 The total synthesis of merrilactone a |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003047501A3 Novel anti-cancer therapeutic compounds |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | WO2002102976A3 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | WO2002066435B1 Metal complexes and therapeutic uses thereof |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | US20040153071 Interspinous process distraction system and method with positionable wing and method |
| 08/05/2004 | US20040152906 Sulfonamides |